Qi Roberta Zeng from Miami, FL, age 57

License Records

Qi Zeng

License #:

07618 - Active

Category:

Accountants

Issued Date:

Aug 8, 2014

Expiration Date:

Jun 30, 2019

Type:

Certified Public Accountant

Lawyers & Attorneys

Qi Zeng

Name / Title

Company / Classification

Phones & Addresses

Qi Zeng
Portfolio Manager

Acadian Asset Management
Investment Management · Asset Management Services · Investment Advisory Service · Investment Advice · Financing Consultants

260 Franklin St, Boston, MA 02110
Boston, MA 02109
1 Post Office Sq, Boston, MA 02109
10 Post Office Sq, Boston, MA 02109
(617)9463500, (617)9123000, (617)9463501, (617)8503500

Us Patents

Aryltetrazole Compounds, And Compositions Thereof
view source
US Patent:

7087631, Aug 8, 2006
Filed:

Jul 17, 2003
Appl. No.:

10/620619
Inventors:

Alex Nivorozhkin - West Roxbury MA, US
John Van Duzer - Georgetown MA, US
Garry Southan - Lynn MA, US
Siya Ram - Winchester MA, US
Qi Zeng - North Andover MA, US
Assignee:

Inotek Pharmaceuticals Corporation - Beverly MA
International Classification:

A61K 31/41
C07D 257/04
US Classification:

514381, 548253
Abstract:

The present invention relates to 5-Aryltetrazole Compounds, compositions comprising an effective amount of a 5-Aryltetrazole Compound, and methods for treating an inflammation disease, a reperfusion disease, or hyperuricemia in an animal in need thereof comprising administering to the animal an effective amount of a 5-Aryltetrazole compound.

5-Aryltetrazole Compounds And Uses Thereof
view source
US Patent:

7135491, Nov 14, 2006
Filed:

Jan 6, 2005
Appl. No.:

11/030536
Inventors:

Alex Nivorozhkin - West Roxbury MA, US
John Van Duzer - Georgetown MA, US
Andrew Salzman - Belmont MA, US
Garry Southan - Lynn MA, US
Siya Ram - Winchester MA, US
Qi Zeng - North Andover MA, US
Csaba Szabo - Gloucester MA, US
Assignee:

Inotek Pharmaceuticals Corp. - Beverly MA
International Classification:

A61K 31/41
US Classification:

514381
Abstract:

The present invention relates to 5-Aryltetrazole Compounds, compositions comprising an effective amount of a a 5-Aryltetrazole Compound, and methods for treating an inflammation disease, a reperfusion disease, or hyperuricemia in an animal in need thereof comprising administering to the animal an effective amount of a 5-Aryltetrazole compound.

5-Aryltetrazole Compounds, Compositions Thereof, And Uses Therefor
view source
US Patent:

20040019208, Jan 29, 2004
Filed:

Jul 18, 2002
Appl. No.:

10/197609
Inventors:

Alex Nivorozhkin - West Roxbury MA, US
John Van Duzer - Georgetown MA, US
Andrew Salzman - Belmont MA, US
Garry Southan - Lynn MA, US
Siya Ram - Winchester MA, US
Qi Zeng - North Andover MA, US
Csaba Szabo - Gloucester MA, US
International Classification:

C07D413/02
C 07D 4 3/02
C07D257/10
US Classification:

544/132000, 546/210000, 548/253000
Abstract:

The present invention relates to 5-Aryltetrazole compounds, compositions comprising a 5-Aryltetrazole compound, and methods for treating an inflammation disease, a reperfusion disease, hyperuricemia, gout, or tumor-lysis syndrome in an animal in need thereof comprising administering to the animal an effective amount of a 5-Aryltetrazole compound.

5-Aryltetrazoles Compounds And Compositions Thereof
view source
US Patent:

20050159418, Jul 21, 2005
Filed:

Jan 6, 2005
Appl. No.:

11/030416
Inventors:

Alex Nivorozhkin - West Roxbury MA, US
John Van Duzer - Georgetown MA, US
Garry Southan - Lynn MA, US
Siya Ram - Winchester MA, US
Qi Zeng - North Andover MA, US
International Classification:

A61K031/5377
A61K031/454
C07D413/02
C07D043/02
A61K031/41
US Classification:

514235500, 514326000, 514381000, 548253000, 544132000, 546210000
Abstract:

The present invention relates to 5-Aryltetrazole Compounds, compositions comprising an effective amount of a a 5-Aryltetrazole Compound, and methods for treating an inflammation disease, a reperfusion disease, or hyperuricemia in an animal in need thereof comprising administering to the animal an effective amount of a 5-Aryltetrazole compound.

Inhibitors Of Fatty Acid Binding Protein
view source
US Patent:

20120122837, May 17, 2012
Filed:

Sep 23, 2011
Appl. No.:

13/242426
Inventors:

CLIFFORD CHENG - CAMBRIDGE MA, US
XIAOHUA HUANG - BROOKLINE MA, US
YING HUANG - BERKELEY HEIGHTS NJ, US
NING SHAO - WATCHUNG NJ, US
ASHWIN RAO - MORGANVILLE NJ, US
ANANDAN PALANI - BRIDGEWATER NJ, US
PETER ORTH - NEW YORK NY, US
JOHANNES H. VOIGT - CRANFORD NJ, US
ROBERT J. HERR - VOORHEESVILLE NY, US
LANA MICHELE ROSSITER - CLIFTON PARK NY, US
QI ZENG - DELMAR NY, US
XIANFENG SUN - GUILDERLAND NY, US
International Classification:

A61K 31/498
A61K 31/5377
A61K 31/4709
C07D 413/06
A61K 31/506
C07D 471/04
C07D 403/06
C07D 401/14
A61K 31/4985
C07D 403/14
C07D 241/44
A61P 3/04
A61P 3/10
A61P 9/10
A61P 3/06
A61K 31/55
US Classification:

51421018, 51421705, 5142348, 514249, 514312, 540599, 544116, 544295, 544350, 544354, 546157
Abstract:

The present invention relates to novel heterocyclic compounds as Fatty Acid Binding Protein (“FABP”) inhibitors, pharmaceutical compositions comprising the heterocyclic compounds and the use of the compounds for treating or preventing a cardiovascular disease, a metabolic disorder, obesity or an obesity-related disorder, diabetes, dyslipidemia, a diabetic complication, impaired glucose tolerance or impaired fasting glucose.

Resumes

Discupla

view source

Location:

Berkeley, CA

Industry:

Higher Education

Work:

Dominican School of Philosophy & Theology
Discupla
Dominican School of Philosophy & Theology
Graduate Student
China Life Asset Management Company Apr 2011 - Jul 2012
General Manager of Global Market Department
Acadian Ambulance Nov 2006 - Mar 2011
Portfolio Manager
State Street 2005 - 2006
Chief Global Quantitative Analyst

Education:

Dominican School of Philosophy & Theology 2016
Masters, Religious Studies, Philosophy University of Miami 2013 - 2013
Eureka Academy, Madrid, Spain 2012 - 2012
International School, Aix - En - Provence, France 2012 - 2012
Harvard University 1993 - 1996
University of Illinois at Chicago 1991 - 1993
Master of Science, Masters, Mathematics, Computer Science, Statistics

Skills:

Financial Services

Languages:

French

Senior Vice President

view source

Location:

Chicago, IL

Industry:

Management Consulting

Work:

Ernst & Young - Cleveland/Akron, Ohio Area since Feb 2011
Staff - Valuation & Business Modeling
Morgan Stanley Smith Barney Aug 2010 - Dec 2010
Intern
HSBC Feb 2009 - Apr 2009
Management Trainee
Hongta Securities Co. Ltd. Dec 2008 - Jan 2009
Intern
ICBC Jul 2007 - Aug 2007
Summer Intern

Education:

Case Western Reserve University - Weatherhead School of Management 2009 - 2011
Kunming University of Science and Technology 2005 - 2009

Skills:

Financial Modeling
Valuation
Financial Analysis
Finance
Business Valuation
Investments
Mergers and Acquisitions
Analysis
Financial Reporting
Financial Planning
Strategic Financial Planning
Investment Management
Corporate Finance
Due Diligence
Financial Services
Analytical Skills
Succession Planning
Decision Modeling

Interests:

Traveling
Basketball
Reading
Running
Consumer Electronics

Languages:

Mandarin
English

Certifications:

Chartered Financial Analyst (Cfa)
Series 79
Series 63
Cfa Institute
Financial Industry Regulatory Authority (Finra)

Qi Zeng

view source

Qi Zeng

view source

Qi Zeng

view source

Qi Zeng

view source

Qi Zeng West New York, NJ

view source

Work:

CVA for Foreign Exchange Swap

May 2013 to May 2013 Statistic Trading Strategy

Sep 2012 to Dec 2012
main programmer Investment Portfolio Project, Stevens Institute of Technology

Jan 2012 to May 2012

Education:

STEVENS INSTITUE OF TECHNOLOGY
Hoboken, NJ
May 2013
Master of Science in Financial Engineering and Financial Risk Engineering XIAMEN UNIVERSITY
Xiamen, CN
Jul 2011
Bachelor of Economics in Mathematical Economics